Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study

BACKGROUND: Tipepidine (3-[di-2-thienylmethylene]-1-methylpiperidine) has been used solely as a nonnarcotic antitussive in Japan since 1959. The safety of tipepidine in children and adults has already been established. It is reported that tipepidine inhibits G-protein-coupled inwardly rectifying pot...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Sasaki, Tsuyoshi, Hashimoto, Kenji, Tachibana, Masumi, Kurata, Tsutomu, Okawada, Keiko, Ishikawa, Maki, Kimura, Hiroshi, Komatsu, Hideki, Ishikawa, Masatomo, Hasegawa, Tadashi, Shiina, Akihiro, Hashimoto, Tasuku, Kanahara, Nobuhisa, Shiraishi, Tetsuya, Iyo, Masaomi
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2014
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908907/
https://ncbi.nlm.nih.gov/pubmed/24493927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S58480
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы